Trials / Unknown
UnknownNCT02203227
Efficacy and Safety Study of Dietary Supplements in Chronic Smokers Having Mild to Moderate Hyperlipidemia
Efficacy and Safety Study of Dietary Supplements (BioTurmin, BioTurmin-WD and MaQxan) on Cotinine Level and Oxidative Stress Marker in Chronic Smokers Having Mild to Moderate Hyperlipidemia
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Olive Lifesciences Pvt Ltd · Industry
- Sex
- Male
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy and safety of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) on cotinine level and oxidative stress marker in chronic smokers having mild to moderate hyperlipidemia after 30 and 60 days of intervention.
Detailed description
In a randomized, double-blind, placebo control trial, the efficacy and safety of dietary supplements (BioTurmin, BioTurmin-WD and MaQxan) will be investigated in chronic smokers having mild to moderate hyperlipidemia. Sixty subjects will be randomly assigned to receive the dietary supplements and placebo for 60 days. The efficacy of the supplements will be measured by estimating cotinine and malondialdehyde level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Placebo | |
| DIETARY_SUPPLEMENT | BioTurmin (Curcuma longa rhizomes extract) | |
| DIETARY_SUPPLEMENT | BioTurmin-WD (Water dispersible curcuminoids) | |
| DIETARY_SUPPLEMENT | MaQxan |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2015-02-01
- Completion
- 2015-02-01
- First posted
- 2014-07-29
- Last updated
- 2014-07-29
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02203227. Inclusion in this directory is not an endorsement.